Safe Superintelligence is reportedly nearing a funding round that would stand out even in the capital-heavy world of artificial intelligence. The startup, founded by former OpenAI chief scientist Ilya Sutskever, could raise more than $1 billion at a $30 billion valuation, according to Bloomberg.
The reported deal shows how strongly investors are still willing to back elite AI teams, even when a company is not yet selling products. In this case, Safe Superintelligence is not generating revenue yet and does not intend to sell AI products in the near future.
A large round for a company built around a long horizon
The potential fundraising round would be led by VC firm Greenoaks Capital Partners, which is reportedly pledging to invest half a billion dollars. If the terms do not change, the round would bring Safe Superintelligence's total raised to roughly $2 billion.
That figure is notable because the company is still early in its commercial life. The source article states that Safe Superintelligence is not generating revenue yet. It also says the startup does not intend to sell AI products in the near future.
That combination makes the reported valuation especially important. A $30 billion valuation is not being tied to current product sales in the article. Instead, it reflects investor interest in the company's founding team, its area of focus, and the belief that its work could become highly valuable later.
The article also notes that the reported $30 billion valuation is higher than what had been reported just weeks ago. That suggests investor appetite around the company may have intensified quickly, though the source does not provide more detail on the earlier figure.
Why Ilya Sutskever matters to the deal
Ilya Sutskever is a central reason Safe Superintelligence is drawing attention. The source describes him as widely respected in the AI and wider tech industry. It also says he is credited with contributing to major AI breakthroughs while at OpenAI.
One of those contributions, according to the article, was the technical approach that made ChatGPT's development possible. That history gives investors a clear reason to watch his next company closely.
In AI, technical leadership can be a major part of a startup's early value. Some companies raise around products already in the market. Others raise around a team that investors believe can solve difficult technical problems before a business model is fully visible.
Safe Superintelligence appears to fit the second pattern based on the facts in the source. The company has not begun generating revenue, and it is not planning near-future AI product sales. Yet it has still attracted major backers and may soon add more than $1 billion in new funding.
The founding team adds to the investor signal
Safe Superintelligence was not built around Sutskever alone. The founding team also includes ex-OpenAI researcher Daniel Levy and former Apple AI projects lead Daniel Gross.
That background matters because the company is operating in one of the most technically demanding areas of technology. The source does not describe the company's internal research plans in detail, but the name Safe Superintelligence points clearly to the kind of ambition investors are evaluating.
The startup has already raised money from Sequoia Capital, Andreessen Horowitz, and DST Global. Those names add another layer to the market signal. The reported Greenoaks Capital Partners-led round would build on an existing base of prominent investors rather than representing the company's first major outside validation.
For readers tracking AI fundraising, the important detail is not only the size of the round. It is the gap between the company's commercial status and the reported investor demand. Safe Superintelligence is being valued at a level that many companies only reach after proving substantial market traction, while the article says this startup is not yet generating revenue.
What the reported valuation says about AI funding
The reported deal highlights a broader reality of frontier AI investing: some investors are willing to fund research-heavy companies long before ordinary business metrics can be applied. In this case, the article gives no revenue figure because the company is not generating revenue yet.
That does not make the round irrational on its face. It means the bet is structured around future potential rather than present sales. Investors appear to be pricing in the possibility that a small number of AI teams could create unusually valuable technology if they succeed.
Several facts from the source point to that logic:
- Safe Superintelligence could raise more than $1 billion.
- The reported valuation is $30 billion.
- Greenoaks Capital Partners is reportedly leading the deal.
- The firm is pledging to invest half a billion dollars.
- The round would bring total raised to roughly $2 billion if terms do not change.
- The company is not generating revenue yet.
- The company does not intend to sell AI products in the near future.
Taken together, those points describe a company being funded for what it may become, not for what it is currently selling. That is a familiar pattern in deep technology, but the scale here is what makes the report stand out.
The key uncertainty is timing
The source article does not say when Safe Superintelligence might bring products to market. In fact, it says the company does not intend to sell AI products in the near future. That leaves open a central question for investors and the broader industry: how long will backers be willing to wait?
For now, the reported round suggests the answer may be: long enough to support a large research effort. If the terms remain unchanged, Safe Superintelligence would have raised roughly $2 billion in total, giving it substantial resources for work that may not be commercially visible soon.
The story is therefore not just about another large AI funding round. It is about how much value the market is willing to assign to a respected AI founder, a high-profile technical team, and a company pursuing artificial intelligence without immediate product sales.